We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis to Assist Bayer in U.S. Validation of Betaseron Facility
Novartis to Assist Bayer in U.S. Validation of Betaseron Facility
April 2, 2007
As part of a legal settlement, Novartis will assist Bayer Schering Pharma in obtaining FDA validation of Bayer’s outsourced European Betaseron manufacturing facility, Bayer told DGR March 27. The facility is operated by Boehringer Ingelheim.